News Author: HT Staff Publish date: December 5, 2014
Credit: CDC
Tamoxifen, a drug used to treat breast cancer, may be effective against myeloproliferative neoplasms (MPNs) and acute myeloid leukemia ...
News Author: HT Staff Publish date: December 5, 2014
Credit: AFIP
The US Food and Drug Administration (FDA) has expanded the approved use of ruxolitinib (Jakafi) to include treatment of patients with ...
News Author: HT Staff Publish date: December 5, 2014
Credit: Linda Bartlett
The UK’s National Institute for Health and Care Excellence (NICE) has issued a draft guidance that recommends obinutuzumab, ...
News Author: HT Staff Publish date: December 4, 2014
Credit: Piotr Bodzek
New research suggests that, as the duration of surgery increases, so does the risk of venous thromboembolism (VTE).
Compare...
News Author: HT Staff Publish date: December 4, 2014
Credit: Rhoda Baer
The American Society of Hematology (ASH) has released a second list of 5 commonly used tests, treatments, and procedures that ph...
News Author: HT Staff Publish date: December 4, 2014
Credit: NIAID
The US Food and Drug Administration (FDA) has granted accelerated approval for blinatumomab (Blincyto) to treat adults with relapsed ...
News Author: HT Staff Publish date: December 3, 2014
Credit: Rhoda Baer
A new study suggests that half of all people recently diagnosed with cancer in England and Wales should survive their disease fo...
News Author: HT Staff Publish date: December 3, 2014
The European Medicines Agency (EMA) has granted orphan drug designation for selinexor (KPT-330) to treat multiple myeloma (MM) and chronic lymphocy...
News Author: HT Staff Publish date: December 3, 2014
Actimab-A consists of the CD33 antibody lintuzumab linked to the actinium-225 payload.
News Author: HT Staff Publish date: December 3, 2014
Credit: Globovision
The UK’s National Institute for Health and Care Excellence (NICE) has issued a final draft guidance recommending eculizumab (So...
News Author: HT Staff Publish date: December 2, 2014
Inhibiting the enzyme 5-lipoxygenase (5-LO) can eradicate cancer stem cell-like cells (CSCs) in acute myeloid leukemia (AML), according to a preclinic...
News Author: HT Staff Publish date: December 2, 2014
chemotherapy
Credit: Rhoda Baer
The UK’s National Institute for Health and Care Excellence (NICE) has updated its guidance to expand the use of er...
News Author: HT Staff Publish date: December 2, 2014
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for the oral proteasome inhibitor ixazomib (MLN9708) to treat r...
News Author: HT Staff Publish date: December 2, 2014
Credit: Esther Dyson
The US Department of Health and Human Services (HHS) has proposed a rule that would require more public disclosure of clinical...
News Author: HT Staff Publish date: December 1, 2014
Credit: Graham Colm
Two teams of researchers have identified somatic mutations that increase the likelihood a person will develop a hematologic mal...
